Target intelligence / Profile preview

Plasmodium glutathione reductase

Molecular classification
Enzyme, Flavoenzyme
01

Overview

Plasmodium glutathione reductase is a homodimeric flavoenzyme essential for the malaria parasite's antioxidant defense system. It catalyzes the reduction of oxidized glutathione disulfide (GSSG) to reduced glutathione (GSH) using NADPH, maintaining the intracellular redox balance necessary for parasite survival. While structurally similar to the human enzyme, the Plasmodium enzyme contains notable differences at ligand-binding sites, which are exploited for selective inhibitor design. Glutathione reductase is not essential for parasite asexual blood stage growth but becomes critical for the mosquito oocyst stage. It is a validated antimalarial drug target due to its indispensable role in the parasite's protection from oxidative stress and its structural divergence from the host enzyme.

Other names
Glutathione reductase (Plasmodium)GR (Plasmodium)Plasmodium falciparum glutathione reductase
02

Mechanism of action

Inhibition of glutathione reductase disrupts the parasite's redox balance, impairs antioxidant defense, and leads to oxidative stress and death of the malaria parasite.

03

Biological functions

Antioxidant defenseRedox homeostasisMaintenance of reduced glutathione (GSH) levels
04

Disease associations

Infection (malaria)
05

Safety considerations

Potential for off-target toxicity due to similarity with the human enzymeRisk of host red blood cell oxidative injury, especially in individuals with G6PD or GR deficiency
06

Interacting drugs

Methylene blue

2 more in the full profile.

07

Biomarkers

Reduced/oxidized glutathione ratio in infected cellsAltered GR activity as a marker of parasite redox state and drug response

Beyond the preview

Go deeper on Plasmodium glutathione reductase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium glutathione reductase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call